ORLENA WYATT: Open Payments
NPI 1851791446 · LOCUST GROVE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,374 in 55 payments from 14 companies in 2025. Trend: 2023 $1,336 · 2024 $1,758 · 2025 $1,374
Food & beverage: $1,374
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $385 |
| Ardelyx, Inc. | 9 | $192 |
| Ipsen Biopharmaceuticals, Inc | 2 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $137 |
| GENZYME CORPORATION | 4 | $114 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Madrigal Pharmaceuticals | 2 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Lilly USA, LLC | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
Products named: RINVOQ, IBSRELA, DUPIXENT, IQIRVO, ENTYVIO, CREON, REZDIFFRA, LINZESS.
Industry payments across GA — which companies pay providers there.
